Related content

Conversations with Mike Milken

The Pioneer, with the National Cancer Institute’s Steven Rosenberg

When Steven Rosenberg joined the National Cancer Institute more than 45 years ago, he was determined to prove that a patient’s own immune system could be used to fight cancer. His interleukin-2 therapy was approved by the FDA for cancer in 1992, leading to many more advances and resulting in thousands of lives extended and saved. 


For a limited time: Become a Charter Member!